Press Releases

News Brief

Samsung Biologics presents at Contract Pharma Webinar (TUE 9/15, 2pm EDT)

Join us for a free webinar! Faster & Better Your Success to IND & BLA Through S-CHOice Cell Line & 2-Step Purification Platform Tue, Sep 15 2PM EDT
 
 

At Samsung Biologics, our team of experts will be holding a webinar, hosted by Contract Pharma, on the 15th of September to explain how we can support our clients get to IND faster through S-CHOice, our accelerated and high performance proprietary cell line, and our 2-step purification platform strategy. 

 

John Gill, Director of Cell Line Development, and Beomkyu Kim, Lead Scientist of Downstream Process Development, will discuss how we combine S-CHOice and 2-step purification platform together to further expedite the 3 months cell line development timeline and reduce the manufacturing costs. 

 

To learn more about our webinar, please click here 

Join us for a free webinar! Faster & Better Your Success to IND & BLA Through S-CHOice Cell Line & 2-Step Purification Platform Tue, Sep 15 2PM EDT
 
 

At Samsung Biologics, our team of experts will be holding a webinar, hosted by Contract Pharma, on the 15th of September to explain how we can support our clients get to IND faster through S-CHOice, our accelerated and high performance proprietary cell line, and our 2-step purification platform strategy. 

 

John Gill, Director of Cell Line Development, and Beomkyu Kim, Lead Scientist of Downstream Process Development, will discuss how we combine S-CHOice and 2-step purification platform together to further expedite the 3 months cell line development timeline and reduce the manufacturing costs. 

 

To learn more about our webinar, please click here

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION